Fresenius Medical Care AG filed its 2026 AGM invitation, proposing a €1.49 dividend, a new 5-year treasury share authorization, and the election of PwC as auditor, alongside its audited 2025 Compensation Report.
Key takeaways
The Company proposes a dividend of €1.49 per share for fiscal year 2025, representing a 3% increase.
Shareholders will vote on a new authorization to purchase and use treasury shares up to 10% of share capital for five years until May 20, 2031.
The share buyback program initiated in August 2025 acquired 14.1 million shares for €586 million in the first tranche.
Dr. Katarzyna Mazur-Hofsäß and Dr. Franklin W. Maddux retired from the Management Board effective December 31, 2025.
PricewaterhouseCoopers GmbH is proposed for election as auditor and group auditor for fiscal year 2026.